January 22, 2018 12:49 PM ET

Life Sciences Tools and Services

Company Overview of Ajinomoto Althea, Inc.

Company Overview

Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company also provides services related to drug substances, such as cGMP protein/plasmid DNA production, microbial cell banking, patented protein expression technology, analytics, and regulatory support. In addition, it offers drug product manufacturing services, including formulation, aseptic vial filling, aseptic pre-filled syringe filling, lyophilization, stability and rele...

11040 Roselle Street

San Diego, CA 92121

United States

Founded in 1997





Key Executives for Ajinomoto Althea, Inc.

CEO & President
Age: 53
Co-Founder and Director
Age: 58
VP of Finance & CFO
Vice President of Human Resources
Vice President of Biologics
Compensation as of Fiscal Year 2017.

Ajinomoto Althea, Inc. Key Developments

Althea CMO Presents at Peptalk – The Protein Science Week, Jan-11-2018 03:05 PM

Althea CMO Presents at Peptalk – The Protein Science Week, Jan-11-2018 03:05 PM. Venue: San Diego, California, United States. Speakers: Lynette Schroeter, Group Lead, Formulations Development.

Ajinomoto Althea, Inc. to Open GMP Production Suite in Newly Constructed High Potency Products Commercial Manufacturing Facility in San Diego

Ajinomoto Althea, Inc. (Althea) announced it will soon open a GMP production suite in its newly constructed High Potency Products (HPP) commercial manufacturing facility located in San Diego, CA. Althea took ownership of the new facility on May 1, 2015 and phased construction and retrofitting commenced in January 2016. Althea is currently offering process development and analytical services to clients from the new facility and will be open for GMP bioconjugation and complex formulation in November 2017. Althea anticipates full manufacturing services including high containment fill and finish will commence in fourth quarter of 2018. The new Althea facility is uniquely designed to develop, manufacture, test, and release HPPs including Antibody Drug Conjugates (ADCs), Highly Potent Active Pharmaceutical Ingredients (HPAPIs), and other complex formulations of highly potent drugs.

Ajinomoto Althea, Inc. Presents at World ADC San Diego, Sep-21-2017 11:00 AM

Ajinomoto Althea, Inc. Presents at World ADC San Diego, Sep-21-2017 11:00 AM. Venue: Sheraton San Diego Marina, 1380 Harbor Island Dr, San Diego, California, United States. Speakers: Michael Molony, Director, Analytical Development & QC.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
NYC2012, Inc. United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ajinomoto Althea, Inc., please visit altheacmo.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.